Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 171.97M | 181.86M | 109.56M | 81.10M | 77.99M |
| Total Depreciation and Amortization | 58.95M | 59.56M | 56.33M | 59.73M | 62.11M |
| Total Amortization of Deferred Charges | 37.80M | 37.80M | 44.00M | 44.00M | 44.00M |
| Total Other Non-Cash Items | 60.44M | 54.16M | 108.51M | 96.40M | 88.73M |
| Change in Net Operating Assets | 8.45M | -41.30M | -23.55M | -31.92M | -21.57M |
| Cash from Operations | 337.60M | 292.07M | 294.86M | 249.32M | 251.25M |
| Capital Expenditure | -29.40M | -28.85M | -25.26M | -26.30M | -27.20M |
| Sale of Property, Plant, and Equipment | 0.00 | 4.62M | 5.28M | 5.28M | 7.06M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.68M | 6.04M | 9.26M | 7.24M | 7.24M |
| Cash from Investing | -22.72M | -18.19M | -10.73M | -13.78M | -12.89M |
| Total Debt Issued | -- | -- | 66.00M | 104.00M | 104.00M |
| Total Debt Repaid | -100.00M | -146.00M | -196.00M | -144.00M | -104.00M |
| Issuance of Common Stock | 93.30M | 80.62M | 64.42M | 49.33M | 50.13M |
| Repurchase of Common Stock | -51.80M | -53.82M | -110.96M | -211.14M | -286.52M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -50.03M | -49.92M | -49.82M | -49.88M | -50.15M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.53M | -169.11M | -226.36M | -251.69M | -286.54M |
| Foreign Exchange rate Adjustments | -1.28M | -2.24M | 11.38M | 11.48M | 5.60M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 205.07M | 102.53M | 69.15M | -4.67M | -42.58M |